Mirae Asset Global ETFs Holdings’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$801K Sell
39,388
-4,063
-9% -$82.7K ﹤0.01% 1554
2025
Q1
$798K Buy
43,451
+680
+2% +$12.5K ﹤0.01% 1606
2024
Q4
$1.08M Buy
42,771
+3,830
+10% +$96.7K ﹤0.01% 1503
2024
Q3
$1.32M Buy
38,941
+3,529
+10% +$120K ﹤0.01% 1382
2024
Q2
$1.31M Buy
+35,412
New +$1.31M ﹤0.01% 1308